| ABP | Acute bacterial prostatitis |
| ATP | Adenosine triphosphate |
| AUC | Area under the concentration time curve |
| CIP | Category I prostatitis |
| CIIP | Category II prostatitis |
| CBP | Chronic bacterial prostatitis |
| CLSI | Clinical and laboratory standards institute |
| cAMP | Cyclic adenosine monophosphate |
| ECOFF | Epidemiological cut-off |
| EUCAST | European Committee on Antimicrobial Susceptibility Testing |
| ESBL | Extended spectrum beta-lactamases |
| G6P | Glucose-6-phosphate |
| UhpT | Hexose-6-phosphate transport systems |
| IV | Intra-venous |
| GlpT | L-alpha-glycerophosphate transport system |
| MRSA | Methicillin resistant Staphylococcus aureus |
| MIC | Minimum inhibitory concentration |
| MDR | Multidrug resistant |
| NIH | National Institutes of Health |
| PD | Pharmacodynamic |
| PK | Pharmacokinetic |
| PTS | Sugar phosphotransferase system |
| TURP | Transurethral resection of the prostate |
| UDPMurNAc | UDP N-acetylmuramic acid |
| UNAG | UDP-N-acetylglucosamine |
| UTI | Urinary tract infections |
| Vd | Volume of distribution |